Dr. David Greene R3 Stem Cell
Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells) and adipocytes (fat cells). They are found in many tissues, including bone marrow, adipose tissue, umbilical cord, and skin.
Aging frailty is a physical condition that is associated with a progressive decline in physical and cognitive function that occurs with advancing age. It is characterized by a loss of muscle mass, strength, and coordination, as well as an increased risk of falls, fractures, and other medical complications. It is a common problem in the elderly population, and can lead to disability and decreased quality of life.
• Improved physical and cognitive performance
• Reduced risk of falls and fractures
• Improved immune system functioning
• Increased longevity
• Reduced risk of adverse effects
• Improved safety profile
• Minimal invasiveness
• Limited availability of MSCs
• Limited understanding of the long-term effects
• Difficulty in accurately assessing the efficacy of the therapy
• MSC therapy has the potential to improve physical and cognitive performance in aging frailty.
• Clinical studies have shown promising results.
